Peter Collins

Peter Collins has held various positions in the healthcare industry since 2006. In 2006, they were the CBO of Pronostics (Smartbead). From 2007 to 2009, they were the SVP Business Development of DxS Limited, and from 2009 to 2010 they were the VP Pharma Business Development of QIAGEN. In 2011, they founded and became a Board Member of EPEMED. From 2014 to 2019, they were the Chief Business Officer of Yourgene Health. From 2019 to 2020, they were the Vice President Biopharma BD of Guardant Health, and from 2020 to 2021 they were the Independent Director of miDiagnostics and the CEO of SAGA Diagnostics AB.

Peter Collins attended Shebbear College from 1970 to 1977 and then the University of Plymouth from 1977 to 1980, where they earned a BSc in Biological Sciences.